The Institute of Occupational Medicine (IOM) is a major independent centre of scientific excellence in the fields of occupational and environmental health, hygiene, and safety. Established in 1969, it has been fully independent since 1990.
The IOM’s research and consultancy expertise covers a wide range of scientific disciplines, including epidemiology, human exposure assessment, statistical inference and modelling, health effects, mechanisms of disease and data management systems. We also have extensive experience in the development and testing of new sampling methods and equipment.
IOM is closely involved in many nanotechnology risk and research issues through leading and participating in several key reviews commissioned by the UK Government in response to the Royal Society Report and other projects. We run the SAFENANO information service (www.safenano.org) on nanoparticle risk issues, a primary source of information for industry, with a focus on collecting and interpreting the emerging scientific evidence on these issues. IOM participates in many of the major networks linked to nanoparticle risk issues such as ISO 229 WG3 Nanotechnology: Safety, Health and Environment; the EU Framework 7 Programme advisory board.
IOM has extensive working experience in many recent and current FP projects. We are/were major partners in NANOMMUNE, NANOTEST, NANCORE, NANODEVICE, NANOIMPACTNET and NANOREG. IOM has also led several FP projects such as PARTICLE_RISK, HEIMTSA, NANEX and ENPRA and is currently leading MARINA. In NANOSOLUTIONS IOM will assist in data management systems development in WP11, Systems Biology Analysis, and will lead WP12, Safety Classification.